| Scientific Name | Ofatumumab |
|---|---|
| Brand Name | Arzerra |
| Risk | Hepatitis B virus reactivation warning, Safety update on a fatal infusion reaction reported in a patient with Chronic lymphocytic leukemia (Cll) who was treated with intravenous ofatumumab, Risk of Progressive Multifocal Encephalopathy (PML) Following Ofatumumab Use. |
| Safety Communication for Healthcare Professionals |
